WU, Yuting. Pembrolizumab in the Precision Immunotherapy of Sinonasal Malignancies. MedScien, [S. l.], v. 4, n. 4, p. 7242, 2026. DOI: 10.61173/s6kscx48. Disponível em: https://ms.deanfrancis.press/article/view/84. Acesso em: 23 oct. 2026.